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The combined infl uence of age, smoking, alcohol, blood lead and cadmium concentrations, and serum 
copper, zinc, and selenium concentrations on prostate-specifi c antigen (PSA) in serum was investigated 
in a group of 57 men aged 21 years to 40 years. The subjects had no occupational exposure to metals and 
no other known reasons suspected of infl uencing prostate function or metal metabolism. No signifi cant 
correlation was found between PSA and any of the explanatory variables considered. Nevertheless, when 
taking into account all of the above-mentioned potentially explanatory variables, the results of stepwise 
multiple regression showed a signifi cant increase in PSA with respect to an increase in blood lead, and a 
decrease in PSA with respect to an increase in intensity of alcohol consumption. The median and range 
values of blood lead concentration in the 57 men were 26.0 µg L-1 and (10.1 to 108.0) µg L-1, respectively. 
These results suggest that even a low-level environmental lead exposure, common for general populations 
worldwide, may contribute to the risk of prostate cancer in men. The infl uence of lead as well as cadmium, 
zinc, and selenium on prostate damage and PSA should be further investigated in relatively young men 
for the purpose of disease prevention. 
KEY WORDS: cadmium exposure, human environmental lead exposure, lifestyle factors, prostate damage, 
toxic and essential metals interaction.
Prostate-specifi c antigen (PSA), combined with 
digital rectal examination of the prostate, is used as 
an aid in the detection of prostate cancer in men. PSA 
is mainly synthesised in and secreted from epithelium 
of prostate tissue, and it correlates positively with age 
and prostate volume (1).
Prostate cancer is one of the most frequently 
diagnosed cancers in men worldwide. In Croatia in 
2005, it was diagnosed in 13 % of all newly diagnosed 
cancers in men (2). Malignant transformation of 
prostate and progression of carcinoma appear to be 
the consequence of a complex series of initiation and 
promotional events under genetic and environmental 
influences. The most important risk factors are 
age, family history of disease, race and country 
of residence. The possible role of environmental 
and lifestyle factors, including smoking, alcohol 
consumption, and diet, has been suggested and is 
widely debated (3-6).
Lead (Pb) and cadmium (Cd) are toxic metals, 
both are pervasive in the human environment and 
accumulate in the human body over a lifetime. 
In spite of a decreasing trend of Pb exposure in 
Croatia (7-11) and worldwide, Pb toxicity remains 
a signifi cant public health problem. Recent evidence 
has indicated that even low-to-moderate blood lead 
(BPb) levels can signifi cantly reduce human semen 
quality (8, 10, 12). Pb compounds have been classifi ed 
by the International Agency for Research on Cancer 
(IARC) as possible human carcinogens (Group 2B) 
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on the basis of suffi cient evidence of carcinogenicity 
in experimental animals, but inadequate evidence 
of carcinogenicity in humans (13-15). Based on the 
published data, Pb can induce DNA damage as a 
consequence of complex biological events, which 
follow one another. It is likely that the Pb-related 
depletion of glutathione (GSH) and/or increased 
production of reactive oxygen species (ROS) may 
be the trigger in the induction of oxidative stress 
that causes specifi c responses, depending also on the 
functional cellular characteristics. The lymphocytes 
of Pb-exposed workers seem to respond to a chronic 
state of oxidative stress by mechanisms that involve 
downregulation of protein kinase Cα, an effect 
that is commonly seen with other tumor promoters 
(16). Evaluating the possible role of environmental 
exposure to Pb as a risk factor for prostate pathology 
in men suffering from prostate cancer and benign 
prostate hyperplasia (BPH), Siddiqui et al. (17) found 
that BPb was signifi cantly higher in prostate cancer 
and BPH cases than in control subjects. Blood levels 
of zinc (Zn) and copper (Cu) were signifi cantly lower 
in prostate cancer and BPH cases than in controls. 
In all the three groups, a statistically significant 
positive correlation between BPb and thiobarbituric 
acid reactive substances (TBARS), measured as 
malondialdehyde, and inverse correlation between 
BPb and the antioxidant GSH level were observed 
after adjusting for age as a possible confounder. 
However, positive association between BPb and 
TBARS was relatively more pronounced in prostate 
cancer patients than in BPH and controls. These results 
suggest that environmental exposure of men to Pb 
may be a risk factor for prostate cancer and/or benign 
prostate hyperplasia, possibly through the generation 
of ROS and/or reducing the level of Zn which acts 
as a cellular growth protector (17). Cd has been 
designated as a human carcinogen (Group 1) based on 
its carcinogenicity to the lung (18). In several studies, 
Cd is indicated as a potential carcinogen for the human 
prostate (15, 19, 20), although other studies did not 
fi nd any signifi cant association between occupational 
exposure to Cd and prostate cancer (21, 22). In a 
study of men from a Cd-polluted area in China, 
Zeng et al. (23) found a signifi cant dose-response 
relationship between urinary Cd concentration and 
the prevalence of cases with abnormal PSA, while 
blood Cd concentration in subjects with abnormal 
fi ndings on digital rectal examination of the prostate 
was signifi cantly higher than in subjects with normal 
fi ndings. Results of a study by van Wijngaarden et al. 
(24) suggest the protective effect of an increased Zn 
intake on Cd-induced prostatic injury. Namely, these 
authors observed a signifi cant positive correlation 
between urinary Cd concentration and PSA levels 
(after the interaction with Zn was taken into account) 
only when dietary Zn intake levels were low. Further 
investigation is needed to provide better insight 
into those Pb-related and Cd-related mechanisms of 
prostate cancer in men.
Zn and selenium (Se) are essential elements for male 
reproductive function (15, 25, 26). Epidemiological 
studies and randomised intervention trials suggest that 
the risk of prostate cancer in men can be reduced by an 
increased intake of Se (27-29) or Zn (24). Furthermore, 
Cu, Zn, and Se are the co-factors essential for optimal 
activity of the antioxidant enzymes Cu,Zn-dependent 
intracellular superoxide dismutase (SOD) and Se-
dependent glutathione peroxidase (GPx), that play a 
key role in protecting cells against oxidative damage. 
It is known that oxidative stress is implicated in the 
pathogenesis of over 100 human diseases, including 
cancer. A defi ciency of Zn and Se, and to a lesser 
extent of Cu, can have adverse consequences for 
disease susceptibility and maintenance of optimal 
health (26, 30, 31). Pb and Cd can interfere with 
the metabolism of Cu, Zn, and Se by affecting their 
absorption, distribution, and bioavailability in the 
body; can contribute to oxidative stress; and can inhibit 
DNA repair (11, 15, 32-35). On the other hand, Zn 
and Se may act as Pb and Cd antagonists and thus 
mask the Pb-related and/or Cd-related adverse health 
effects (33). In the human general population, the most 
important sources of each of the above-mentioned 
metals are food, water, and air. The levels of blood 
Pb (BPb), blood Cd (BCd), serum Cu (SCu), serum 
Zn (SZn) and serum Se (SSe) are commonly used as 
biomarkers of metal body burden in humans, and are 
known to depend on age, sex, stress, dietary habits, 
smoking, and alcohol consumption. 
Alcohol consumption has been extensively 
studied in relation to prostate cancer, yet fi ndings 
on the direction of the association are equivocal (6). 
Overall results, however, indicate that alcohol may 
be predicted to have both adverse and benefi cial 
effects on prostate carcinogenesis. The oxidative 
stress hypothesis implies that alcohol would act 
early in the prostate carcinogenesis pathway, and 
thus alcohol consumption would adversely affect the 
overall incidence of prostate cancer. The hormone 
hypothesis implies that alcohol would reduce 
hormonal promotion of the growth of prostate tumors. 
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Namely, alcohol intake alters sex hormone levels 
into profi les that would be predicted to decrease the 
risk of prostate cancer. Whether men who drank 
every day (i.e. regularly) did not have an increased 
risk of prostate cancer because they have sustained 
depression of testosterone relative to oestrogen, needs 
further evaluation (6). 
This study considers the combined infl uence of 
age, smoking, alcohol consumption, BPb, BCd, SCu, 
SZn, and SSe on the serum concentration of PSA in 
men with no occupational exposure to metals.
SUBJECTS AND METHODS
Study population
The study was carried out in 57 male subjects who 
had never been occupationally exposed to metals. 
The subjects were randomly selected among those 
reporting for examination in the andrology unit of the 
Vuk Vrhovac Clinic in Zagreb. The group contained 
subjects from couples with suspect infertility (who 
were not necessarily abnormal themselves) and 
voluntary candidates for semen donation for artifi cial 
insemination (who were not necessarily normal or 
accepted for this purpose), examined in random 
order under identical conditions. In order to ensure 
optimal methodological conditions for each subject, 
the examination was carried out on particular days 
of the week when each of the patients and semen 
donor candidates was equally considered for possible 
selection and inclusion in the study. The selection 
criteria were age (20 to 40) years; absence of a 
disease, condition, or exposure to physical and/or 
chemical factors that affect or are suspected to affect 
spermatogenesis or semen quality; and the absence 
of acute disease, or high body temperature during the 
preceding 4 months [period that exceeds the duration 
of one spermatogenesis cycle of approximately (72 
± 9) days]. None of the selected subjects had been 
occupationally exposed to thermal, ionizing or 
microwave irradiation, pesticides, herbicides, organic 
solvents, anesthetics and vinyl chloride, or used 
dietary supplements containing Cu, Zn, Se, Mg and Fe, 
which could infl uence male reproductive parameters 
or metal metabolism. All subjects gave informed 
consent before inclusion in the study. The study was 
performed in accordance with the ethical principles 
for medical research involving human subjects (the 
World Medical Association Declaration of Helsinki, 
revised in October 2000) and was approved by the 
ethical committee of each of the two collaborating 
institutions in Zagreb.
A questionnaire including data on age, dietary 
habits, smoking, alcohol consumption, and professional 
and medical history was completed by a physician for 
each of the 57 subjects. The structured interview 
included questions on exposure to physical and 
chemical agents (based on an exposure checklist, with 
the names of the present and all previous organisations 
of employment and job titles, which were used for 
the individual exposure validation by a specialist in 
occupational health), use of dietary supplements, etc. 
The question with regard to dietary habits consisted 
of 3 options: mixed food, vegetarian with fi sh, or 
vegetarian without fi sh. All 57 subjects declared mixed 
food consumption. There were 23 smokers and 34 
nonsmokers, and 24 consumers and 33 nonconsumers 
of alcohol. The questions with regard to the habits 
of smoking and alcohol consumption each consisted 
of 3 options: never, former, or current, including the 
time of cessation (year), duration period, and the habit 
intensity for the latter two options. For the calculations, 
data on the intensity of smoking (average number of 
cigarettes per day) and alcohol consumption (average 
number of “drinks”, i.e. units of alcohol per week) in 
the previous 4 months were used, by assuming the 
value of zero cigarettes per day and zero “drinks” per 
week for nonsmokers and nonconsumers of alcohol, 
respectively (see Table 1). 
Sampling and analyses of biological specimens
For each subject, venous blood was sampled at 
the Vuk Vrhovac Clinic between 08:00 h and 10:00 
h. All subjects were required to fast in the preceding 
10 h, abstain from alcohol in the preceding 24 h, and 
avoid any sexual activity in the preceding 4 days. 
Special care was taken to avoid any contamination 
with metals during the blood sampling, storage, and 
analyses. The chemicals used for metal analyses 
were of analytical grade for spectroscopy (Merck, 
Darmstadt, Germany).
In all 57 subjects, the following measurements 
were performed for assessment of the metal body 
burden: BPb, BCd, SCu, SZn and SSe. The BPb and 
BCd measurements were performed by electrothermal-
atomic absorption spectrometry (AAS) method, 
essentially the same as the one described for seminal 
plasma Pb and Cd determination (36), controlled 
daily for accuracy by analyzing three reference blood 
samples with certifi ed BPb and BCd values: BCR 
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no. 194 to 196 (Community Bureau of Reference, 
European Commission, Brussels, Belgium). The 
accuracy of both BPb and BCd measurements was also 
controlled by the laboratory’s regular participation in 
the National External Quality Assessment Scheme 
(Birmingham, UK) and our mean running variance 
index score (MRVIS) was consistently lower than the 
average MRVIS for all participants. The SCu and SZn 
measurements were performed by fl ame-AAS method 
(37), controlled daily for accuracy by analyzing two 
reference serum samples with certifi ed SCu and SZn 
values: Seronorm (Nycomed Pharma, Oslo, Norway) 
and Second Generation (J. Versieck, Gent, Belgium). 
SSe was measured by electrothermal-AAS method 
(38), controlled daily for accuracy by analyzing two 
reference serum samples with certifi ed SSe values: 
Seronorm (Nycomed Pharma, Oslo, Norway) and 
Second Generation (J. Versieck, Gent, Belgium). 
The accuracy of SCu, SZn, and SSe measurements 
was also controlled by the laboratory’s regular 
participation in the Trace Elements External Quality 
Assessment Scheme (Guildford, UK) and our results 
were consistently categorized as being Acceptable 
(as opposed to Borderline or Unacceptable as the 
remaining two options).
PSA concentration in serum was measured by 
automated method using a chemiluminescence 
immunoassay Advia Centaur system (Siemens 
Medical Solutions Diagnostics, Tarrytown, NY, 
USA).
Statistical methods
Because of the skewed distribution of most of 
the measured parameters, the results are presented 
as range, and the 5th, the 50th (median), and the 95th 
percentile values. The signifi cance of the difference 
in BCd and BPb between the subgroups of smokers 
and nonsmokers was calculated using the Mann-
Whitney U-test (z, p). Spearman’s rank correlation (r, 
p) was calculated for associations between each of the 
measured parameters. Forward stepwise linear multiple 
regression was used to calculate the interrelationship 
of all the parameters considered possible explanatory 
variables (which were simultaneously introduced in 
the model) with respect to PSA.
RESULTS
Table 1 shows data for the variables measured 
in the study population. The BPb values indicate a 
low-level exposure to Pb in all of the 57 subjects. 
Exposure to Cd was mostly through smoking and 
thus the difference in BCd between the 23 smokers 
and 34 nonsmokers was highly signifi cant (z=5.970, 
p<0.0001). The median and range BCd values in 
these subgroups were 4.01 µg L-1 (0.25 to 6.83) µg L-1 
and 0.25 µg L-1 (0.03 to 0.97) µg L-1, respectively. 
Smokers also had a signifi cantly higher BPb than 
nonsmokers (z=2.424, p<0.02); the median and range 
BPb values were 37.0 µg L-1 (10.1 to 108.0) µg L-1 and 
23.8  µg L-1 (10.1 to 58.0) µg L-1, respectively.
The results of Spearman correlation between 
each of the variables measured in the 57 subjects 
showed no signifi cant association between PSA and 
any of the possible explanatory variables considered 
(age, smoking, alcohol, BPb, BCd, SCu, SZn, and 
SSe). A signifi cant positive correlation was found 
between SCu and SZn (r=0.424, p=0.001), between 
BPb and BCd (r=0.417, p<0.002), between smoking 





PSA / µg L-1 0.2 to 1.7 0.3 0.5 1.4
Age / years 21.6 to 40.2 23.5 32.4 38.7
Smoking / cigarettes per day 0 to 40 0 0 35
Alcohol / drinksa per week 0 to 35 0 0 30
BPb / µg L-1 10.1 to 108.0 11.0 26.0 70.0
BCd / µg L-1 0.03 to 6.83 0.11 0.33 5.94
SCu / µg L-1 698 to 1275 770 970 1232
SZn / µg L-1 611 to 1266 688 962.5 1158
SSe / µg L-1 53 to 95 54 73 91
BPb = blood lead; BCd = blood cadmium; SCu = serum copper; SZn = serum zinc; SSe = serum selenium
aOne drink = 3 dL of beer, 1 dL of wine, or 0.3 dL of brandy.
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and alcohol (r=0.621, p<0.0001), smoking and BCd 
(r=0.820, p<0.0001), and smoking and BPb (r=0.344, 
p<0.009), and between alcohol and BCd (r=0.614, 
p<0.0001), and alcohol and BPb (r=0.473, p=0.0002). 
These signifi cant correlations indicate a complex 
association among all these variables, suggesting the 
possibility that certain variables may mask a causal 
effect of other variables on PSA.
Table 2 shows the results of forward stepwise linear 
multiple regression in 57 subjects when PSA, as a 
dependent variable, was considered with respect to all 
of the following independent (explanatory) variables: 
age, smoking, alcohol, BPb, BCd, SCu, SZn, and 
SSe. The explanatory variables were simultaneously 
introduced in the model, and none of them was removed 
from the model throughout the stepwise procedure. 
Beta (β) is the standardised regression coeffi cient, 
whereas the coeffi cient B value relates to the units 
of measurement actually used for the dependent 
variable and independent (explanatory) variables in the 
equation. The advantage of β coeffi cients (as compared 
to B coeffi cients which are not standardised) is that 
their magnitude allows for a direct comparison of the 
relative contribution of each independent variable 
in the prediction of the dependent variable, even for 
variables measured on disparate ranges or expressed 
in noncomparable units of measurement. The p-value 
of β is equal to the p-value of B.
After adjusting for potentially confounding 
variables by multiple regression, the results (Table 2) 
showed a signifi cant association between an increase 
in BPb and an increase in PSA (β=0.333, p=0.030), 
and between an increase in intensity of alcohol 
consumption (drinks per week) and a decrease in 
PSA (β=-0.327, p=0.033). Exactly the same results 
were obtained when, in separate regression models, 
the multiplicative interaction term BPb*BCd or 
BPb*alcohol was introduced together with all of 
the remaining potentially explanatory variables 
considered (age, smoking, alcohol, BPb, BCd, SCu, 
SZn, and SSe), indicating that neither BCd nor alcohol 
had modifi ed the observed signifi cant effect of BPb on 
PSA. However, an independent effect of alcohol on 
PSA was observed (Table 2) that was in the opposite 
direction to that of BPb on PSA.
Essentially the same results were obtained when 
data for the dependent variable (PSA) included in 
the regression model were logarithmically (log) 
transformed in order to produce their normal (Gaussian) 
distribution. This resulted in the same explanatory 
variables that entered the regression equation (i.e. BPb 
and alcohol), although the corresponding β- and p-
values showed a slightly greater relative contribution 
to the effect on PSA, and a better level of signifi cance 
for the given explanatory variable, as compared to 
those shown in Table 2. These results were β=-0.397, 
p=0.009 for alcohol, and β=0.381, p=0.012 for BPb. 
Exactly the same results were obtained when either 
BPb*BCd or BPb*alcohol was introduced in the 
regression model together with all of the remaining 
potentially explanatory variables, confi rming that 
neither BCd nor alcohol interacted with BPb and 
thus did not modify the observed signifi cant effect of 
BPb on PSA.
All of the 57 men in this study had normal fi ndings 
on digital rectal examination of the prostate; the 
absence of prostatitis and any signifi cant increase in 
estimated prostate volume were found.
DISCUSSION
The BPb level in the study population (Table 1) is 
comparable to the levels found in adult male general 
population groups in many countries worldwide. In 
general, men have commonly higher BPb levels than 
women (15). The reported geometric mean BPb values 
for the general population groups, comprising men 
Table 2  Summary of the multiple regression results for associations between prostate-specifi c antigen (PSA), as the dependent 
variable, considered with respect to all of the potentially explanatory variables (age, smoking, alcohol, BPb, BCd, 
SZn, SCu, and SSe)a in 57 male subjects
Variable Beta Coeffi cient (B) Standard error of B p
PSA
Intercept  0.4459 0.0836 0.0000
BPb  0.333  0.0058 0.0026 0.0305
Alcohol -0.327 -0.0109 0.0050 0.0335
aExactly the same results were obtained when, in separate regression models, the multiplicative interaction term BPb*BCd or 
BPb*alcohol was introduced together with all of the above-mentioned explanatory variables.
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and women, from the United States and Japan were 
28 µg L-1 (39) and 23.2 µg L-1 (40), respectively.
The BCd level in the study population (Table 1) is 
comparable to the levels found in general population 
groups in many other countries. Increased BCd 
levels in our study population can mainly be ascribed 
to smoking, and the relatively high Cd content in 
Croatian cigarettes. In Croatian heavy smokers, BCd 
levels of up to 13 µg L-1 were commonly found (7, 8, 
41, 42). The geometric mean BCd values reported for 
10 countries, including Belgium, China, India, Israel, 
Japan, Mexico, Peru, Sweden, USA and Croatia (in 
former Yugoslavia), ranged from 0.2 µg L-1 (Sweden) 
to 1.5 µg L-1 (Belgium) for nonsmokers, and from 
0.6 µg L-1 (India) to 2.8 µg L-1 (Croatia) for smokers 
(7), whereas those of a meta analysis in Italian subjects 
were 0.52 µg L-1 for nonsmokers and 1.47 µg L-1 
for smokers (43). The BCd levels for nonsmokers 
in this study [median: 0.25 µg L-1, range: (0.03 to 
0.97) µg L-1] and in our previous studies (7, 8, 41, 
42, 44) are comparable to or even lower than those in 
other countries.
The levels of SCu, SZn, and SSe in the study 
population (Table 1) are comparable to those for 
healthy adult general population groups in many other 
countries, although the range of published values is 
relatively wide. For example, the reported range for 
SCu was (600 to 1760) µg L-1 in Italian subjects (45) 
and (585 to 2027) µg L-1 in German subjects (46), 
and that for SZn was (540 to 1510) µg L-1 in Italian 
subjects (45) and (608 to 1510) µg L-1 in German 
subjects (46). Variations in SSe levels are particularly 
pronounced, both between different countries and 
within some countries such as the United States 
and China, which is mainly because of the large 
differences in Se concentration in soil (47); among 20 
countries considered, the lowest average SSe values 
(<80 µg L-1) are found in New Zealand and generally 
in the eastern European countries, whereas the highest 
average SSe values have been reported from the 
seleniferous regions in the United States (198 µg L-1) 
and China (490 µg L-1).
Epidemiological studies of combined exposure 
to various metals that may influence individual 
susceptibility to adverse health effects are generally 
lacking. Similarly to our previous fi ndings in men 
(9-11, 42, 44), signifi cant correlations were found 
between smoking habits, alcohol consumption, BPb, 
and BCd in the group of men in this study. With 
regard to the hypothesis that Pb and/or Cd adversely 
affect prostate function and may also infl uence PSA 
level in men, these variables may be both potential 
confounders and risk factors.
After adjusting for a possible infl uence on PSA 
of each of the explanatory variables considered in 
the study population, the multiple regression results 
(Table 2) showed a small, albeit signifi cant BPb-
related increase in PSA. It is important to note that 
the study population consisted of relatively young 
men [age median: 32 years, range: (21 to 40) years] 
known to be at lower risk of prostate cancer compared 
to elderly men. Furthermore, the BPb values in the 
study population indicate a low-level exposure to 
Pb (Table 1) with regard to the currently acceptable 
BPb limit of 100 µg L-1 for the general population, 
including children, who are particularly susceptible 
to Pb toxicity (15). 
In addition to direct toxicity of Pb on the prostate 
secretory function in men, as indicated by a signifi cant 
Pb-related decrease in seminal plasma concentrations 
of Zn, acid phosphatase, and citric acid (8, 10, 25, 48), 
there are two plausible mechanisms for Pb-induced 
prostate damage that may ultimately progress into 
prostate cancer. One is related to the role of Pb through 
oxidative stress (15, 17, 33, 35, 49, 50). The other 
concerns a signifi cant Pb-related increase in serum 
testosterone, observed at low-to-moderate levels of 
chronic exposure to Pb in men (8, 10). This may 
have implications on the initiation and development 
of prostate cancer, because testosterone is known 
to augment the progress of prostate cancer in its 
early stages. It is interesting to note that the highest 
prevalence of prostate cancer in the general population 
of men has been reported for African Americans, 
known to commonly have relatively higher BPb levels 
than other ethnic groups in the United States.
Published evidence on the possible association 
between an increased risk of prostate cancer and 
Pb and/or Cd in occupationally exposed men is 
inconclusive (15). This may partly be explained by the 
fact that in many circumstances an increased exposure 
to these toxic metals is combined. Furthermore, 
occupational and environmental exposures to each of 
these metals are usually combined with exposure to the 
essential metal Zn that can act as an antagonist of the 
Pb-related and Cd-related reproductive toxicity (15, 
25, 33). Thus it is important to simultaneously measure 
biomarkers of Pb, Cd, and Zn body burden and to 
control and adjust for each other, when evaluating 
the effect of any of these metals on PSA and prostate 
function in men.
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With regard to the observed signifi cant inverse 
association between PSA and intensity of alcohol 
consumption (drinks per week) after adjusting 
for potentially confounding variables by multiple 
regression (Table 2), it is important to note that alcohol 
consumption signifi cantly positively correlated with 
BPb in the study population (r=0.473, p=0.0002). 
This association between alcohol consumption and 
BPb is common in humans (9-11, 44, 51) because 
alcoholic beverages contain an appreciable amount 
of Pb, and also because ethanol metabolism alters 
redox potential in the body and thus can mobilise the 
biologically inert fraction of accumulated Pb from the 
bones into the peripheral blood. Therefore, it seems 
possible that some of the reported alcohol-induced 
adverse effects on prostate carcinogenesis in men, 
reviewed by Platz et al. (6), may in fact be causally 
related to Pb, since those studies did not address Pb 
as a possible confounder. Furthermore, the oxidative 
stress hypothesis related to the effect of alcohol on 
prostate carcinogenesis (6) seems not to be plausible in 
view of decreased (rather than increased) erythrocyte 
lipid peroxidation in alcohol drinkers compared to 
controls, which was particularly evident in subjects 
who consumed more than 140 g of alcohol per day 
(52). However, the infl uence of alcohol consumption 
on PSA and prostate cancer in men still appears 
equivocal. For further elucidation, more studies on a 
large number of men should be done by performing a 
thorough control and adjustment for many potential 
confounders, including BPb in particular. 
In conclusion, after adjusting for potentially 
confounding variables by multiple regression, this 
study has shown a signifi cant positive association 
between PSA and BPb. This was observed in relatively 
young men at a low-level environmental Pb exposure 
common for general populations worldwide. With 
regard to the possibly related risk of prostate cancer, 
the infl uence of Pb, Cd, Zn, and Se on prostate damage 
and PSA should be further investigated in relatively 
young men for the purpose of disease prevention.
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Sažetak
PROSTATNI SPECIFIČNI ANTIGEN (PSA) U SERUMU U ODNOSU NA KONCENTRACIJU OLOVA 
U KRVI I KONZUMIRANJE ALKOHOLA U MUŠKARACA
Zajednički utjecaj dobi, pušenja, alkohola, koncentracija olova i kadmija u krvi te koncentracija bakra, cinka 
i selenija u serumu na prostatni specifi čni antigen (PSA) u serumu istražen je u skupini od 57 muškaraca 
dobi od 21 do 40 godina. Ispitanici nisu bili profesionalno izloženi metalima niti su imali druge poznate 
razloge za sumnju o mogućem utjecaju na funkciju prostate ili na metabolizam metala. Nije nađena značajna 
korelacija između PSA i bilo koje od razmatranih uzročnih varijabla. Međutim, nakon što su uzete u obzir 
sve navedene potencijalno uzročne varijable, rezultati postupne višestruke regresije pokazali su značajan 
porast PSA u odnosu na porast olova u krvi, kao i značajno sniženje PSA u odnosu na porast intenziteta 
konzumiranja alkohola (broj jedinica alkohola na tjedan). Vrijednosti medijana i raspona koncentracije 
olova u krvi u toj skupini muškaraca bile su 26,0 µg L-1 te 10,1 µg L-1 do 108,0 µg L-1. Rezultati upućuju 
na mogućnost da čak i niska razina izloženosti olovu iz okoliša, uobičajena za opće populacije diljem 
svijeta, može pridonijeti opasnosti od raka prostate u muškaraca. Potrebno je daljnje istraživanje utjecaja 
olova i također kadmija, cinka i selenija na oštećenje prostate i na PSA u relativno mladih muškaraca u 
svrhu prevencije bolesti.
KLJUČNE RIJEČI: interakcija toksičnih i esencijalnih metala, čimbenici načina života, čovjekova 
izloženost olovu iz okoliša, izloženost kadmiju, oštećenje prostate
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